# Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine

> **NCT03542227** · — · COMPLETED · sponsor: **Universiteit Antwerpen** · enrollment: 63 (actual)

## Conditions studied

- Human Papilloma Virus Infection

## Interventions

- **OTHER:** First-void urine collection
- **OTHER:** Blood draw

## Key facts

- **NCT ID:** NCT03542227
- **Lead sponsor:** Universiteit Antwerpen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-11
- **Primary completion:** 2022-01-11
- **Final completion:** 2022-06-23
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2022-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03542227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03542227, "Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03542227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*